RENEWALUXE SPF 50 Sunscreen

Manufacturer
Guangzhou Fantesy Biotechnology Co.,Ltd
Effective date
2026-01-06
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 01:31:25

Label at a glance#

ProductRENEWALUXE SPF 50 Sunscreen
Active ingredientZINC OXIDE
Label structure9 sections

Indications and uses

Uses Helps prevent sunburn. If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Dosage and administration

Directions Apply liberally 15 minutes before sun exposure Reapply: After 40 minutes of swimming or sweating ■Immediately after towel drying ■At least every 2 hours ■Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Lim...

Storage and handling

Protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION


Zinc Oxide 21.8%

OTC - PURPOSE SECTION

sunscreen

Uses

INDICATIONS & USAGE SECTION

Uses Helps prevent sunburn. If used as directed with other sun
protection measures (see Directions), decreases the risk of
skin cancer and early skin aging caused by the sun.

Warnings

WARNINGS SECTION

Warnings
For external use only
Do not use on damaged or broken skin.
When using the product keep out of eyes. Rinse with water to remove.Stop use and ask a doctor if rash occurs.

Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center right away.

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
If swallowed, get medical help or
contact Poison Control Center
right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions Apply liberally 15 minutes before sun exposure Reapply: After 40 minutes of
swimming or sweating
■Immediately after towel drying
■At least every 2 hours
■Sun Protection Measures: Spending time in the sun increases your risk of skin cancer
and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum

SPF value of 15 or higher and other sun protection measures including: Limit time in the sun,
especially from 10a.m. - 2p.m.
■Wear long-sleeve shirts, pants, hats, and sunglasses.
■Children under 6 months: Ask a doctor.

Other information

STORAGE AND HANDLING SECTION

Protect the product in this container from excessive heat and direct sun

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

22

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83447-005-01RENEWALUXE SPF 50 Sunscreen50 mL in 1 BOXCREAM504

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83447-00583447-005-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RENEWALUXE SPF 50 SunscreenRENEWALUXE SPF 50 SUNSCREENGuangzhou Fantesy Biotechnology Co.,Ltd1bc29960-5e73-e8ab-e063-6294a90a3f802026-01-06WarningsExact identifier
ndc (package): 83447-005-01
ndc (product): 83447-005
ndc11 (package): 83447000501
spl id: 47b31ef5-e027-ed4b-e063-6294a90a2d30
spl set id: 1bc29960-5e73-e8ab-e063-6294a90a3f80

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.